{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:41:33Z","timestamp":1763750493860,"version":"3.45.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["20K10162, 23K09311"],"award-info":[{"award-number":["20K10162, 23K09311"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    <jats:italic>Fusobacterium nucleatum<\/jats:italic>\n                    (\n                    <jats:italic>Fn<\/jats:italic>\n                    ) is known as an etiological factor related to periodontitis. However, recent reports have shown that it also functions as an oncogenic pathogen and is associated with progression of various cancers as well as poor prognosis of esophageal squamous cell carcinoma (ESCC) patients. The present study was conducted to examine the correlations of serum IgG antibody titer level against\n                    <jats:italic>Fn<\/jats:italic>\n                    (IgG-\n                    <jats:italic>Fn<\/jats:italic>\n                    ) with clinicopathological characteristics, oral conditions, and survival outcomes in 305 patients who underwent an esophagectomy procedure for ESCC. The results revealed that 40.7% of the patients tested positive for IgG-\n                    <jats:italic>Fn<\/jats:italic>\n                    , and those in the positive group had significantly lower rates of overall survival (OS) and cancer-specific survival (CSS) as compared to patients who tested negative (OS;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01, CSS;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.02). Multivariate analysis showed IgG-\n                    <jats:italic>Fn<\/jats:italic>\n                    positivity as an independent predictor of CSS (hazard ratio, 1.96; 95% CI, 1.32\u20132.90;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Moreover, among patients who were diagnosed with stage II-IV and underwent neoadjuvant therapy (NAT), those in the IgG-\n                    <jats:italic>Fn<\/jats:italic>\n                    -positive group showed higher pathological progression and greater incidence of inadequate response to NAT as compared to the IgG-\n                    <jats:italic>Fn<\/jats:italic>\n                    -negative group (odds ratio 0.48, 95% CI 0.24\u20130.92;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.04). The present findings indicate that IgG-\n                    <jats:italic>Fn<\/jats:italic>\n                    can serve as a marker indicating poor tumor response to NAT in advanced ESCC cases.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0336219","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:37:27Z","timestamp":1763750247000},"page":"e0336219","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum IgG titer findings for Fusobacterium nucleatum associated with clinical outcome following surgery in patients with esophageal squamous cell carcinoma"],"prefix":"10.1371","volume":"20","author":[{"given":"Toru","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-9886","authenticated-orcid":true,"given":"Hiromi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Emi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Hamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Ibuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Hirohata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manato","family":"Ohsawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Kitasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Komatsuzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"2","key":"pone.0336219.ref001","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","article-title":"Epidemiology of Esophageal Squamous Cell Carcinoma","volume":"154","author":"CC Abnet","year":"2018","journal-title":"Gastroenterology"},{"issue":"26","key":"pone.0336219.ref002","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMra1314530","article-title":"Esophageal carcinoma","volume":"371","author":"AK Rustgi","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"pone.0336219.ref003","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1902\/jop.2005.76.8.1406","article-title":"Position paper: epidemiology of periodontal diseases","volume":"76","author":"Research, Science and Therapy Committee of the American Academy of Periodontology","year":"2005","journal-title":"J Periodontol"},{"issue":"6","key":"pone.0336219.ref004","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/odi.13682","article-title":"Effects of perioperative oral care on postoperative inflammation following heart valve surgery","volume":"27","author":"H Nishi","year":"2020","journal-title":"Oral Diseases"},{"issue":"2","key":"pone.0336219.ref005","article-title":"Upper gastrointestinal tract microbiota with oral origin in relation to oesophageal squamous cell carcinoma","volume":"55","author":"S Gao","year":"2023","journal-title":"Annals of Medicine"},{"issue":"3","key":"pone.0336219.ref006","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41579-018-0129-6","article-title":"Fusobacterium nucleatum - symbiont, opportunist and oncobacterium","volume":"17","author":"CA Brennan","year":"2019","journal-title":"Nat Rev Microbiol"},{"issue":"22","key":"pone.0336219.ref007","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1158\/1078-0432.CCR-16-1786","article-title":"Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis","volume":"22","author":"K Yamamura","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"20","key":"pone.0336219.ref008","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1158\/1078-0432.CCR-19-0318","article-title":"Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma","volume":"25","author":"K Yamamura","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"4","key":"pone.0336219.ref009","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1902\/jop.2009.080474","article-title":"Serum antibodies to periodontal bacteria as diagnostic markers of periodontitis","volume":"80","author":"BA Dye","year":"2009","journal-title":"J Periodontol"},{"issue":"1","key":"pone.0336219.ref010","doi-asserted-by":"crossref","first-page":"12353","DOI":"10.1038\/s41598-022-16279-z","article-title":"Treatment resistance of rheumatoid arthritis relates to infection of periodontal pathogenic bacteria: a case-control cross-sectional study","volume":"12","author":"K Takeuchi-Hatanaka","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0336219.ref011","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/cei.13430","article-title":"Serum immunoglobulin G antibody titer to Fusobacterium nucleatum is associated with unfavorable outcome after stroke","volume":"200","author":"H Nishi","year":"2020","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"pone.0336219.ref012","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00535-017-1368-4","article-title":"Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease","volume":"53","author":"T Nakahara","year":"2018","journal-title":"J Gastroenterol"},{"issue":"3","key":"pone.0336219.ref013","first-page":"178","article-title":"The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management","volume":"5","author":"C-H Sun","year":"2019","journal-title":"Chronic Dis Transl Med"},{"issue":"1","key":"pone.0336219.ref014","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13046-018-0985-y","article-title":"Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer","volume":"38","author":"S Zhang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"pone.0336219.ref015","doi-asserted-by":"crossref","first-page":"2306676","DOI":"10.1080\/15384047.2024.2306676","article-title":"Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance","volume":"25","author":"C Ye","year":"2024","journal-title":"Cancer Biol Ther"},{"issue":"10","key":"pone.0336219.ref016","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.3390\/nu13103637","article-title":"A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects","volume":"13","author":"P Mertowska","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"pone.0336219.ref017","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/cas.15787","article-title":"Fusobacterium nucleatum promotes the early occurrence of esophageal cancer through upregulation of IL-32\/PRTN3 expression","volume":"114","author":"J Lei","year":"2023","journal-title":"Cancer Sci"},{"issue":"1","key":"pone.0336219.ref018","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/07853890.2022.2061045","article-title":"Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance","volume":"54","author":"M Liang","year":"2022","journal-title":"Ann Med"},{"key":"pone.0336219.ref019","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jare.2023.08.014","article-title":"Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma","volume":"61","author":"S Guo","year":"2024","journal-title":"J Adv Res"},{"key":"pone.0336219.ref020","doi-asserted-by":"crossref","first-page":"968649","DOI":"10.3389\/fimmu.2022.968649","article-title":"Involvement of Fusobacterium nucleatum in malignancies except for colorectal cancer: A literature review","volume":"13","author":"Z He","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0336219.ref021","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/prd.12426","article-title":"Fusobacterium nucleatum and cancer","volume":"89","author":"T Alon-Maimon","year":"2022","journal-title":"Periodontol 2000"},{"issue":"22","key":"pone.0336219.ref022","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"P van Hagen","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"pone.0336219.ref023","doi-asserted-by":"crossref","first-page":"855","DOI":"10.6004\/jnccn.2019.0033","article-title":"Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"JA Ajani","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"13","key":"pone.0336219.ref024","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/bjs.10627","article-title":"Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma","volume":"104","author":"F Noble","year":"2017","journal-title":"Br J Surg"},{"key":"pone.0336219.ref025","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1245\/s10434-013-3093-4","article-title":"Circulating miR-200c Levels Significantly Predict Response to Chemotherapy and Prognosis of Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Cancer","volume":"20","author":"K Tanaka","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"pone.0336219.ref026","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/SLA.0000000000001489","article-title":"MiRNA Expression Analysis of Pretreatment Biopsies Predicts the Pathological Response of Esophageal Squamous Cell Carcinomas to Neoadjuvant Chemoradiotherapy","volume":"263","author":"J Wen","year":"2016","journal-title":"Annals of Surgery"},{"issue":"5","key":"pone.0336219.ref027","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/SLA.0000000000001911","article-title":"Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer","volume":"264","author":"E Bollschweiler","year":"2016","journal-title":"Annals of Surgery"},{"issue":"6","key":"pone.0336219.ref028","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/gastro\/goaa065","article-title":"Transcriptomic biomarkers for predicting response to neoadjuvant treatment in oesophageal cancer","volume":"8","author":"A Lavery","year":"2021","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"1","key":"pone.0336219.ref029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/SLA.0000000000005473","article-title":"A Transcriptomic Liquid Biopsy Assay for Predicting Resistance to Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma","volume":"276","author":"K Okuno","year":"2022","journal-title":"Annals of Surgery"},{"issue":"12","key":"pone.0336219.ref030","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1177\/0022034512461796","article-title":"Assessment of the plasma\/serum IgG test to screen for periodontitis","volume":"91","author":"C Kudo","year":"2012","journal-title":"J Dent Res"},{"issue":"1","key":"pone.0336219.ref031","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1348-0421.2003.tb02785.x","article-title":"Serum antibodies of periodontitis patients compared to the lipopolysaccharides of Porphyromonas gingivalis and Fusobacterium nucleatum","volume":"47","author":"S Onoue","year":"2003","journal-title":"Microbiol Immunol"},{"issue":"1","key":"pone.0336219.ref032","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-81171-1","article-title":"Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer","volume":"11","author":"M Kurt","year":"2021","journal-title":"Sci Rep"},{"key":"pone.0336219.ref033","volume-title":"TNM Classification of Malignant Tumours","author":"D Brierley","year":"2016","edition":"8"},{"issue":"6","key":"pone.0336219.ref034","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.athoracsur.2015.02.042","article-title":"Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer","volume":"99","author":"Y Hamai","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"pone.0336219.ref035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/wjs.12033","article-title":"Prognostic factors for esophageal squamous cell carcinoma without pathological lymph node metastasis after neoadjuvant therapy and surgery","volume":"48","author":"Y Hamai","year":"2024","journal-title":"World J Surg"},{"issue":"1","key":"pone.0336219.ref036","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00595-023-02702-z","article-title":"The treatment efficacy and prognosis of each treatment in early postoperative recurrence of esophageal squamous cell carcinoma","volume":"54","author":"M Ohsawa","year":"2024","journal-title":"Surg Today"},{"issue":"1","key":"pone.0336219.ref037","first-page":"1","article-title":"Japanese Classification of Esophageal Cancer, 11th Edition: part I","volume":"14","year":"2016","journal-title":"Esophagus"},{"issue":"4","key":"pone.0336219.ref038","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1128\/iai.56.4.855-863.1988","article-title":"Immunobiological activities of a porin fraction isolated from Fusobacterium nucleatum ATCC 10953","volume":"56","author":"H Takada","year":"1988","journal-title":"Infect Immun"},{"issue":"7","key":"pone.0336219.ref039","article-title":"Genome sequence of Fusobacterium nucleatum subspecies polymorphum - a genetically tractable fusobacterium","volume":"2","author":"SE Karpathy","year":"2007","journal-title":"PLoS One"},{"issue":"11","key":"pone.0336219.ref040","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1600-051X.2005.00834.x","article-title":"Relationship between bleeding on probing and periodontal disease progression in community\u2010dwelling older adults","volume":"32","author":"A Rahardjo","year":"2005","journal-title":"J Clinic Periodontology"},{"issue":"1","key":"pone.0336219.ref041","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1038\/s41598-022-06485-0","article-title":"Periodontal inflamed surface area in oral cavity associated with febrile neutropenia in patients with hematologic malignancy undergoing chemotherapy","volume":"12","author":"H Nishi","year":"2022","journal-title":"Sci Rep"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:37:36Z","timestamp":1763750256000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336219"}},"subtitle":[],"editor":[{"given":"David M.","family":"Ojcius","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0336219","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]}}}